Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
UTI Healthcare Fund - Direct Plan - IDCW
UTI Mutual Fund · Managed by Kamal Gada
15weak
Latest NAV
₹298.1564
as of 07 Aug 2026
AUM
—
Expense ratio
1.31%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
15/100weak
Rank #854 of 1007 · top 85%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
4.72%
3M
11.65%
6M
23.26%
1Y
18.61%
3Y CAGR
24.06%
5Y CAGR
16.05%
Since incep.
16.61%
Fund details
- Fund manager
- Kamal Gada
- Riskometer
- Very High Risk
- Type
- Open Ended
- Portfolio turnover
- 30%
- Volatility (3Y)
- 15.4%
- Rating (external)
- —
Investment objective
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap25.8%
Mid cap31.2%
Small cap43.1%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 30 Apr 2026.
EQ - SUN PHARMACEUTICALS INDUSTRIES
equity
9.49%
EQ - AJANTA PHARMA LTD.
equity
5.84%
EQ - LUPIN LTD.
equity
4.23%
EQ - APOLLO HOSPITALS ENTERPRISE LT
equity
3.54%
EQ - DIVIS LABORATORIES LTD.
equity
3.45%
EQ - GLENMARK PHARMACEUTICALS LTD.
equity
3.35%
EQ - DR REDDYS LABORATORIES LTD.
equity
3.35%
EQ - GLAND PHARMA LTD.
equity
3.30%
EQ - FORTIS HEALTHCARE LTD.
equity
3.23%
EQ - ALKEM LABORATORIES LTD
equity
3.21%
EQ - MAX HEALTHCARE INSTITUTE LTD
equity
3.00%
EQ - COHANCE LIFESCIENCES LIMITED
equity
2.96%
EQ - ANTHEM BIOSCIENCES LTD
equity
2.48%
EQ - AUROBINDO PHARMA LTD.
equity
2.46%
EQ - PROCTOR & GAMBLE HEALTH LTD
equity
2.28%
EQ - IPCA LABORATORIES LTD.
equity
2.19%
EQ - CAPLIN POINT LABORATORIES LTD
equity
2.17%
EQ - SAI LIFE SCIENCES LTD
equity
2.15%
EQ- GLOBAL HEALTH LTD.
equity
2.06%
EQ - SUDEEP PHARMA LIMITED
equity
1.99%
EQ - ASTER DM HEALTHCARE LTD
equity
1.99%
EQ - VIYASH SCIENTIFIC LTD
equity
1.95%
EQ- JUPITER LIFE LINE HOSPITALS LTD
equity
1.94%
EQ - MARKSANS PHARMA LTD.
equity
1.83%
EQ - CIPLA LTD.
equity
1.72%
EQ - METROPOLIS HEALTHCARE LTD
equity
1.61%
EQ - RAINBOW CHILDRENS MEDICARE LTD
equity
1.58%
EQ - ERIS LIFESCIENCES LTD
equity
1.56%
EQ - PFIZER LIMITED
equity
1.47%
EQ - KRISHNA INSTITUTE OF MEDI SCIE
equity
1.34%